These success, along with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 aid the notion of targeting ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Proble